Risk and Protective Factors for COVID‐19 Infection among Pregnant Women with Sickle Cell Trait

Abstract

Pregnant women and individuals with sickle cell trait (SCT) and underlying comorbidities are both independently more vulnerable to severe illness from coronavirus disease 2019 (COVID‐19) compared to nonpregnant women and those without SCT. However, our understanding of the specific factors influencing susceptibility to COVID‐19 infection among pregnant women with SCT is currently constrained by limited available data. This study aims to determine the risk and protective factors that influence the likelihood of COVID‐19 infection in this population. A retrospective analysis was done among 151 women with SCT in the reproductive age group. Multivariable analysis was performed to determine the various factors affecting COVID‐19 infection among pregnant women with SCT. The study found that COVID‐19‐vaccinated pregnant women with SCT had a 90% lower risk of contracting COVID‐19 and were 9 times more likely to have a COVID‐19 infection if they had a history of pulmonary conditions such as asthma or chronic obstructive pulmonary disease. The present study further emphasizes the importance of the COVID‐19 vaccine in preventing infection and safeguarding the health of pregnant women with SCT, particularly those with underlying comorbidities.